You are here

  • Home
  • Archive
  • Volume 77, Issue 4
  • Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial
Free

 

Online download statistics by month:

Online download statistics by month: September 2017 to March 2024

AbstractFullPdf
Sep 2017122115394
Oct 201780414394
Nov 20174287162
Dec 20171621619
Jan 20183084833
Feb 2018921810
Mar 20181041911188
Apr 2018479461135
May 201820018675
Jun 201812311554
Jul 20181139347
Aug 2018585620
Sep 2018877922
Oct 2018907832
Nov 2018757330
Dec 2018828231
Jan 2019959133
Feb 2019696544
Mar 2019575132
Apr 2019353023
May 2019444426
Jun 2019323233
Jul 2019504924
Aug 2019434123
Sep 2019504723
Oct 2019393429
Nov 2019282324
Dec 2019484421
Jan 2020595123
Feb 2020656431
Mar 2020292832
Apr 2020424019
May 2020615644
Jun 2020383421
Jul 2020414025
Aug 2020191716
Sep 202033297
Oct 2020454514
Nov 2020302919
Dec 2020232311
Jan 2021312722
Feb 2021181824
Mar 2021181713
Apr 2021232312
May 2021404012
Jun 2021434322
Jul 2021323018
Aug 2021222217
Sep 2021343222
Oct 2021383517
Nov 2021535034
Dec 2021464130
Jan 2022393818
Feb 202230286
Mar 2022342713
Apr 2022373516
May 2022565239
Jun 2022474311
Jul 2022494928
Aug 2022626111
Sep 2022666721
Oct 2022434518
Nov 2022403621
Dec 2022403013
Jan 202340357
Feb 2023555340
Mar 2023222120
Apr 2023252216
May 2023242215
Jun 2023141411
Jul 2023201913
Aug 20231093
Sep 202312124
Oct 202332327
Nov 202332325
Dec 202336348
Jan 202424235
Feb 2024363613
Mar 2024484622
Total780948892190